O papel das incretinas na fisiologia do DM2

Referências

1. Nauck, M. A., & Meier, J. J. (2016). The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions. The Lancet Diabetes & Endocrinology, 4(6), 525–536. doi:10.1016/s2213-8587(15)00482-9

2. Nauck MA, Meier JJ. GIP and GLP-1: stepsiblings rather than monozygotic twins within the incretin family. Diabetes. 2019;68(5):897-900. doi:10.2337/dbi19-0005 

3. Nauck M, Stöckmann F, Ebert R, Creutzfeldt W. Reduced incretin eff ect in type 2 (non-insulin-dependent) diabetes. Diabetologia 1986; 29: 46–52. 9  

4. Knop FK, Vilsbøll T, Højberg PV, et al. Reduced incretin eff ect in type 2 diabetes: cause or consequence of the diabetic state? Diabetes 2007; 56: 1951–59. 

5. Nauck MA, Homberger E, Siegel EG, et al. Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J Clin Endocrinol Metab 1986; 63: 492–98. 

6. Freeman JS. A physiologic and pharmacological basis for implementation of incretin hormones in the treatment of type 2 diabetes mellitus. Mayo Clin Proc. 2010;85(12 suppl):S5-S14. doi:10.4065/mcp.2010.0467  

7. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106(4):473-481. doi:10.1172/JCI10842 

8. Asmar M, Simonsen L, Madsbad S, Stallknecht B, Holst JJ, Bülow J. Glucose-dependent insulinotropic polypeptide may enhance fatty acid re-esterification in subcutaneous abdominal adipose tissue in lean humans. Diabetes. 2010;59(9):2160-2163. doi:10.2337/db10-0098 

9. Kim SJ, Nian C, Karunakaran S, Clee SM, Isales CM, McIntosh CH. GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasis. PLoS One. 2012;7(7):e40156. doi: 10.1371/journal.pone.0040156.  

10. NamKoong C, Kim MS, Jang BT, Lee YH, Cho YM, Choi HJ. Central administration of GLP-1 and GIP decreases feeding in mice. Biochem Biophys Res Commun. 2017 Aug 19;490(2):247-252. doi: 10.1016/j.bbrc.2017.06.031.  

11. Nagashima M, Watanabe T, Terasaki M, Tomoyasu M, Nohtomi K, Kim-Kaneyama J, Miyazaki A, Hirano T. Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice. Diabetologia. 2011 Oct;54(10):2649-59. doi: 10.1007/s00125-011-2241-2.